These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21175918)

  • 1. A web-based study of gamma hydroxybutyrate (GHB): patterns, experiences, and functions of use.
    Stein LA; Lebeau R; Clair M; Martin R; Bryant M; Storti S; Monti P
    Am J Addict; 2011; 20(1):30-9. PubMed ID: 21175918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary web-based measures development for GHB: expectancies, functions, and withdrawal.
    Stein LA; Lebeau R; Clair M; Martin R; Bryant M; Storti S
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):121-9. PubMed ID: 22175869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
    Brennan R; Van Hout MC
    J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to "A web-based study of γ hydroxybutyrate (GHB): patterns, experiences, and functions of use".
    Zvosec D; Smith S
    Am J Addict; 2011; 20(3):300-1. PubMed ID: 21477059
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study.
    Barker JC; Harris SL; Dyer JE
    J Psychoactive Drugs; 2007 Jun; 39(2):115-29. PubMed ID: 17703706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Going knock-Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium).
    Grund JP; de Bruin D; van Gaalen S
    Int J Drug Policy; 2018 Aug; 58():137-148. PubMed ID: 29957565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
    McDaniel CH; Miotto KA
    J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB).
    Sumnall HR; Woolfall K; Edwards S; Cole JC; Beynon CM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):286-90. PubMed ID: 17766059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive sex partying with gamma-hydroxybutyrate: factors associated with using gamma-hydroxybutyrate for chemsex among Australian gay and bisexual men - results from the Flux Study.
    Hammoud MA; Bourne A; Maher L; Jin F; Haire B; Lea T; Degenhardt L; Grierson J; Prestage G
    Sex Health; 2018 Apr; 15(2):123-134. PubMed ID: 29268075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ Hydroxybutyrate use: exploring the influence of outcome expectancies through memory modeling.
    Brown PC; Alfonso J; Dunn ME
    Am J Addict; 2011; 20(2):127-36. PubMed ID: 21314755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
    Palmer RB
    Toxicol Rev; 2004; 23(1):21-31. PubMed ID: 15298490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
    Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
    Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coma and respiratory depression following the ingestion of GHB and its precursors: three cases.
    Ingels M; Rangan C; Bellezzo J; Clark RF
    J Emerg Med; 2000 Jul; 19(1):47-50. PubMed ID: 10863118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
    Miotto K; Darakjian J; Basch J; Murray S; Zogg J; Rawson R
    Am J Addict; 2001; 10(3):232-41. PubMed ID: 11579621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
    Hovda KE; Liberg JP; Nordby G; Jacobsen D
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4390-3. PubMed ID: 9889613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
    Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
    Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma hydroxybutyric acid (GHB) intoxication.
    Mason PE; Kerns WP
    Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.